(Q67927105)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861222%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Topical nitrogen mustard: an effective treatment for cutaneous Langerhans cell histiocytosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861222%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Topical nitrogen mustard: An effective treatment for cutaneous Langerhans cell histiocytosis (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)80752-8

Langerhans cell histiocytosis specific to childhood

12 December 2022

main subject

1 reference

M. P. Sheehan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861222

12 December 2022

D. J. Atherton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861222

12 December 2022

V. Broadbent

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861222

12 December 2022

J. Pritchard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861222

12 December 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861222%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:S0022347605807528?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)80752-8

https://api.elsevier.com/content/article/PII:S0022347605807528?httpAccept=text/plain

12 December 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)80752-8

The Journal of Pediatrics

12 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861222%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861222%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861222%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

317-321

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861222%20AND%20SRC:MED&resulttype=core&format=json

A flow cytometric study of Langerhans cell histiocytosis

19 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Histiocytosis X—an analysis of prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Langerhans cell histiocytosis: the case for conservative treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Histiocytosis X: treatment with topical nitrogen mustard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Hand-Schüller-Christian Disease in a Septuagenarian

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Histiocytosis X in two adults. Treatment with topical mechlorethamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Histiocytosis X of the scalp and face.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Histiocytosis X presenting as intertrigo and responding to topical nitrogen mustard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Histiocytosis X in two infants—treated with topical nitrogen mustard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Contact urticaria and anaphylactoid reaction induced by topical application of nitrogen mustard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Mycosis fungoides, nitrogen mustard and skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Nitrogen mustard (mechlorethamine) and UVB photocarcinogenesis: a dose response effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Results of treatment of 127 patients with systemic histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

No detectable increase in sister chromatid exchanges in lymphocytes from mycosis fungoides patients after topical treatment with nitrogen mustard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980752-8

Topical nitrogen mustard induced carcinogenesis

7 January 2021

23

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)80752-8

12 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861222%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference